(NP (NP Activation/NN) (PP of/IN (NP (NP nuclear/JJ factor/NN) (PP of/IN (NP activated/VBN T/NN cells/NNS)))) (PP in/IN (NP a/DT (ADJP cyclosporin/NN A-resistant/JJ) pathway/NN)) ./.)
(S (NP-SBJ (NP The/DT mechanism/NN) (PP of/IN (NP (NP action/NN) (PP of/IN (NP the/DT immunosuppressive/JJ drug/NN (NP (NP cyclosporin/NN A/NN) (PRN -LRB-/-LRB- (NP CsA/NN) -RRB-/-RRB-))))))) (VP is/VBZ (NP-PRD (NP the/DT inactivation/NN) (PP of/IN (NP the/DT Ca2+\/calmodulin-dependent/JJ serine-threonine/NN phosphatase/NN calcineurin/NN)) (PP by/IN (NP the/DT drug-immunophilin/JJ complex/NN)))) ./.)
(S (NP-SBJ-49 Inactive/JJ calcineurin/NN) (VP is/VBZ (ADJP-PRD unable/JJ (S (NP-SBJ *-49/-NONE-) (VP to/TO (VP activate/VB (NP (NP (NP (NP the/DT nuclear/JJ factor/NN) (PP of/IN (NP activated/VBN T/NN cells/NNS))) (PRN -LRB-/-LRB- (NP NFAT/NN) -RRB-/-RRB-)) ,/, (NP (NP a/DT transcription/NN factor/NN) (VP required/VBN (NP */-NONE-) (PP for/IN (NP (NP expression/NN) (PP of/IN (NP the/DT (NP (NP interleukin/NN 2/CD) (PRN -LRB-/-LRB- (NP IL-2/NN) -RRB-/-RRB-)) gene/NN)))))))))))) ./.)
(S (NP-SBJ-50 (NP IL-2/NN production/NN) (PP by/IN (NP CsA-treated/JJ cells/NNS))) (VP is/VBZ (ADVP therefore/RB) (VP (ADVP dramatically/RB) reduced/VBN (NP *-50/-NONE-))) ./.)
(S (NP-SBJ We/PRP) (VP demonstrate/VBP (ADVP here/RB) ,/, (ADVP however/RB) ,/, (SBAR that/IN (S (S-COOD (S (NP-SBJ-51 NFAT/NN) (VP can/MD (VP be/VB (VP activated/VBN (NP *-51/-NONE-))))) ,/, and/CC (S (NP-SBJ-52 (NP significant/JJ levels/NNS) (PP of/IN (NP IL-2/NN))) (VP can/MD (VP be/VB (VP produced/VBN (NP *-52/-NONE-)))))) (PP by/IN (NP-LGS the/DT CsA-resistant/JJ CD28-signaling/JJ pathway/NN))))) ./.)
(S-COOD (S (PP In/IN (NP transient/JJ transfection/NN assays/NNS)) ,/, (NP-SBJ-53 (NP-COOD both/CC (NP multicopy/JJ NFAT-/NN (NP *RNR*-54/-NONE-)) and/CC (NP IL-2/NN promoter-beta-galactosidase/NN reporter/NN gene/NN (NP *RNR*-54/-NONE-))) (NP-54 constructs/NNS)) (VP could/MD (VP be/VB (VP activated/VBN (NP *-53/-NONE-) (PP by/IN (NP-LGS phorbol/NN 12-myristate/NN 13-acetate/NN -LRB-/-LRB- PMA/NN -RRB-/-RRB- \/alpha-CD28/NN stimulation/NN)))))) ,/, and/CC (S (NP-SBJ this/DT activation/NN) (VP was/VBD (ADJP-PRD resistant/JJ (PP to/TO (NP CsA/NN))))) ./.)
(S (NP-SBJ Electrophoretic/JJ mobility/NN shift/NN assay/NN) (VP showed/VBD (NP (NP the/DT induction/NN) (PP of/IN (NP a/DT CsA-resistant/JJ NFAT/NN complex/NN)) (PP in/IN (NP (NP the/DT nuclear/JJ extracts/NNS) (PP of/IN (NP (NP peripheral/JJ blood/NN T/NN cells/NNS) (VP stimulated/VBN (NP */-NONE-) (PP with/IN (NP-COOD (NP PMA/NN) plus/CC (NP alphaCD28/NN)))))))))) ./.)
(S (NP-SBJ (NP Peripheral/JJ blood/NN T/NN cells/NNS) (VP stimulated/VBN (NP */-NONE-) (PP with/IN (NP PMA\/alphaCD28/NN)))) (VP produced/VBD (NP IL-2/NN) (PP in/IN the/DT presence/NN of/IN (NP CsA/NN))) ./.)
(S (ADVP Collectively/RB) ,/, (NP-SBJ these/DT data/NNS) (VP suggest/VBP (SBAR that/IN (S (S-COOD (S (NP-SBJ-55 NFAT/NN) (VP can/MD (VP be/VB (VP activated/VBN (NP *-55/-NONE-))))) and/CC (S (NP-SBJ-56 IL-2/NN) (VP can/MD (VP be/VB (VP produced/VBN (NP *-56/-NONE-)))))) (PP in/IN (NP a/DT (ADJP calcineurin/NN independent/JJ) manner/NN))))) ./.)
